Trial Profile
Effects on Insulin Resistance With the Phosphodiesterase-5 Inhibitor Tadalafil in Type 2 Diabetes - a Double-blind, Placebo-controlled Crossover Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Benign prostatic hyperplasia; Duchenne muscular dystrophy; Pulmonary hypertension
- Focus Pharmacodynamics
- Acronyms MAKROTAD
- 10 Feb 2020 Status changed from recruiting to completed.
- 10 May 2016 Status changed from not yet recruiting to recruiting.
- 17 Nov 2015 New trial record